Literature DB >> 12694808

Levetiracetam has no significant gamma-aminobutyric acid-related effect on paired-pulse interaction in the dentate gyrus of rats.

Doru Georg Margineanu1, Henrik Klitgaard.   

Abstract

Gamma-aminobutyric acid (GABA)ergic mechanisms of the novel antiepileptic drug, levetiracetam (Keppra), have been both favored and rejected. Since paired-pulse interaction is accepted in functionally assessing GABAergic mechanisms, we investigated whether levetiracetam affects the paired-pulse inhibition/facilitation of the field potentials, evoked in the dentate gyrus of urethane-anesthesized rats. This model revealed a strong paired-pulse inhibition at 20-ms interstimulus interval, a noteworthy paired-pulse facilitation at 80-ms interstimulus interval, and a moderate paired-pulse inhibition at 500-ms interstimulus interval. Bicuculline (3 mg/kg/h, i.v.) and baclofen (10 mg/kg, i.v.) markedly depressed paired-pulse inhibition at 20-ms interstimulus interval, while clonazepam (1 mg/kg, i.p.), diazepam (10 mg/kg, i.v.), and phenobarbital (40 mg/kg, i.v.) enhanced it. Bicuculline also depressed paired-pulse inhibition at 500-ms interstimulus interval. Bicuculline, baclofen, and diazepam reduced paired-pulse facilitation at 80-ms interstimulus interval. Distinct from these GABA(A) receptor- and GABA(B) receptor-related drugs, levetiracetam (17 and 540 mg/kg, i.v.) had no significant effect on either paired-pulse interaction in this model, a result not favoring any major role of GABAergic mechanisms in its antiseizure action.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12694808     DOI: 10.1016/s0014-2999(03)01563-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia.

Authors:  Ming Teng Koh; Yi Shao; Sharon Rosenzweig-Lipson; Michela Gallagher
Journal:  Schizophr Res       Date:  2017-06-17       Impact factor: 4.939

2.  New treatment options in status epilepticus: a critical review on intravenous levetiracetam.

Authors:  Eugen Trinka; Judith Dobesberger
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

3.  Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited.

Authors:  Rainer Surges; Kirill E Volynski; Matthew C Walker
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

4.  A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam.

Authors:  Anna L Meehan; Xiaofeng Yang; Brian D McAdams; Lilian Yuan; Steven M Rothman
Journal:  J Neurophysiol       Date:  2011-06-08       Impact factor: 2.714

5.  Anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGFβ1 regulation.

Authors:  Martin N Stienen; Aiden Haghikia; Hannes Dambach; Jan Thöne; Martin Wiemann; Ralf Gold; Andrew Chan; Rolf Dermietzel; Pedro M Faustmann; Daniel Hinkerohe; Nora Prochnow
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

6.  Levetiracetam inhibits Na+-dependent Cl-/HCO3- exchange of adult hippocampal CA3 neurons from guinea-pigs.

Authors:  Tobias Leniger; Jan Thöne; Udo Bonnet; Andreas Hufnagel; Dieter Bingmann; Martin Wiemann
Journal:  Br J Pharmacol       Date:  2004-07-12       Impact factor: 8.739

7.  Levetiracetam has opposite effects on alcohol- and cocaine-related behaviors in C57BL/6J mice.

Authors:  J Elliott Robinson; Meng Chen; Alice M Stamatakis; Michael C Krouse; Elaina C Howard; Sara Faccidomo; Clyde W Hodge; Eric W Fish; C J Malanga
Journal:  Neuropsychopharmacology       Date:  2013-01-25       Impact factor: 7.853

8.  Levetiracetam for the treatment of hot flashes: a phase II study.

Authors:  Susan Thompson; Aditya Bardia; Angelina Tan; Debra L Barton; Lisa Kottschade; Jeff A Sloan; Brad Christensen; DeAnne Smith; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2007-06-28       Impact factor: 3.603

9.  Levetiracetam inhibits both ryanodine and IP3 receptor activated calcium induced calcium release in hippocampal neurons in culture.

Authors:  Nisha Nagarkatti; Laxmikant S Deshpande; Robert J DeLorenzo
Journal:  Neurosci Lett       Date:  2008-03-21       Impact factor: 3.046

10.  Levetiracetam Prevents Perforin Mediated Neuronal Injury Induced by Acute Cerebral Ischemia Reperfusion.

Authors:  Yue Zhang; Ying Li; Lian Zuo; Huan Bao; Xiahong Xu; Junjie Hao; Xin Wang; Gang Li
Journal:  Mol Neurobiol       Date:  2015-10-10       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.